Revised consolidated earnings guidance for the fiscal year ending March 2027. Net sales increased by 1,190 million yen from the previous forecast, operating income increased by 490 million yen, ordinary income increased by 700 million yen, net income attributable to owners of parent increased by 530 million yen, and diluted net income per share was revised upward from 64.23 yen to 91.30 yen. Strong performance driven by AI-related demand in the pharmaceutical business and a surge in non-ferrous metal prices, prompting an upward revision to full-year outlook. No change to dividend forecast.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4094","jir_company_name":"Nihon Kagaku Sangyo Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-11-09","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4094-20261109-01.pdf","jir_short_summary":"Revised consolidated earnings guidance for the fiscal year ending March 2027. Net sales increased by 1,190 million yen from the previous forecast, operating income increased by 490 million yen, ordinary income increased by 700 million yen, net income attributable to owners of parent increased by 530 million yen, and diluted net income per share was revised upward from 64.23 yen to 91.30 yen. Strong performance driven by AI-related demand in the pharmaceutical business and a surge in non-ferrous metal prices, prompting an upward revision to full-year outlook. No change to dividend forecast.","jir_summary":"### Overview of Revision to Earnings Guidance\nNihon Kagaku Sangyo Co., Ltd. has revised upward its consolidated earnings guidance for the full fiscal year ending March 2027. Net sales are expected to increase by approximately 1,190 million yen, operating income by approximately 490 million yen, ordinary income by approximately 700 million yen, and net income attributable to owners of parent by approximately 530 million yen, with net income per share projected to rise substantially to 91.30 yen.\n\n### Reasons for Revision and Outlook\nThe revision is mainly driven by increased AI-related demand in the pharmaceutical business and a surge in non-ferrous metal prices, with strong expected demand particularly for products for the electronics industry, leading to a projection above the previous full-year forecast. Contract manufacturing of battery cathode materials was completed in August, and demand in the pharmaceutical and building materials segments is also assumed to remain strong, which is expected to support continued growth. There is no revision to the dividend forecast.","jir_financial_highlights":"Net Sales: Previous forecast (A) 28,640 million yen \u2192 Revised forecast (B) 29,830 million yen (Change amount 1,190 million yen, Change rate 4.2%)\nOperating Income: Previous forecast (A) 1,310 million yen \u2192 Revised forecast (B) 1,800 million yen (Change amount 490 million yen, Change rate 37.4%)\nOrdinary Income: Previous forecast (A) 1,800 million yen \u2192 Revised forecast (B) 2,500 million yen (Change amount 700 million yen, Change rate 38.9%)\nNet Income Attributable to Owners of Parent: Previous forecast (A) 1,250 million yen \u2192 Revised forecast (B) 1,780 million yen (Change amount 530 million yen, Change rate 42.4%)\nNet Income Per Share: Previous forecast (A) 64.23 yen \u2192 Revised forecast (B) 91.30 yen (Change amount +27.07 yen)","jir_category":"","jir_hashtags":"#NihonKagakuSangyo, #EarningsGuidanceRevision","jir_key_figures":"Net Sales: 29,830 million yen (previous 28,640 million yen) \nOperating Income: 1,800 million yen (previous 1,310 million yen) \nNet Income Attributable to Owners of Parent: 1,780 million yen (previous 1,250 million yen) ","jir_meta_title":"Nihon Kagaku Sangyo Co., Ltd. Revises Up Earnings Guidance\uff5cFiscal Year Ending March 2027","jir_meta_description":"Nihon Kagaku Sangyo Co., Ltd. has revised up its consolidated earnings guidance for the fiscal year ending March 2027. Sales and profits are significantly higher, supported by AI-related demand and rising non-ferrous metal prices. Dividend forecast remains unchanged.","jir_og_title":"Nihon Kagaku Sangyo Co., Ltd. Revises Up Earnings Guidance","jir_og_description":"Upward revision to full-year forecasts for the fiscal year ending March 2027 against a backdrop of strong AI-related demand and higher non-ferrous metal prices. Confirmed increases in key metrics.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":17390,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"earnings_guidance","footnotes":""},"sector":[],"importance":[],"class_list":["post-144741","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n